Share
Explore BrainMass

Business & HIV/AIDS

Greetings,

I need some detailed assistance for the following topics. I realize you are not a homework completion service, but I would appreciate your help. Refs please and definitely NO PLAGIARISM.

1) Business & HIV/AIDS: The Cost of health care with Aids. I need to define the business angle. What aspects of business do we look to? What is the business of development to treatment, and the ability and cost of treatments to patients?
a. Resource allocation

2) What laws help or hurt the progression of the funding (federally and locally in Massachusetts)?

3) National and local (Massachusetts) focus for funding?

Solution Preview

1) Business & HIV/AIDS: The Cost of health care with Aids. I need to define the business angle. What aspects of business do we look to? What is the business of development to treatment, and the ability and cost of treatments to patients?
a. Resource allocation

Some facts that show that the market for HIV drugs or medication is very attractive from business point of view:

As per data monitor, The HIV drug market is expected to nearly double from $6 billion in 2007 to as much as $11 billion by 2015.

The rise in HIV profits for drug manufacturers is increasing due to multiple reasons. HIV patients on HIV drugs are expected to rely on such drugs for many years and possible few decades and the recent trend has been to treat the disease earlier. New-generation once a day tablets have made the treatment of this disease easier.

Reference: http://articles.latimes.com/2008/feb/21/business/fi-hiv21

Audited financial statements allow an examination of R&D expenditures by companies with dedicated HIV drug programs giving an unusual degree of transparency into the costs of preclinical and clinical drug development. Based on trends in R&D spending by these two companies, an estimate for the total cost of bringing a single HIV drug to market can be plausibly set at a figure approaching $300 million.

Reference:

http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102251054.html

United States HIV/AIDS Testing market is one of the highly developed and regulated markets in the world. HIV/AIDS confirmatory tests market in the region is projected to reach US$32 million by 2015. With disease management taking precedence, new product introductions are likely to become the mainstay of many companies.

Reference: http://www.eatg.org/eatg/Global-HIV-News/Pharma-Industry/HIV-AIDS-testing-market-to-exceed-3.9-billion-by-2015-according-to-new-report-by-Global-Industry-Analysts-Inc

On the basis of above mentioned statistics, it is quite evident that the business prospects of HIV drug development is becoming quite attractive as one pill a day drugs are used by HIV patients for as long as couple of decades and ...

Solution Summary

1) Business & HIV/AIDS: The Cost of health care with Aids. I need to define the business angle. What aspects of business do we look to? What is the business of development to treatment, and the ability and cost of treatments to patients?

$2.19